Average Co-Inventor Count = 9.94
ph-index = 2
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Beijing Tide Pharmaceutical Co., Ltd. (13 from 17 patents)
13 patents:
1. 12485108 - Method for treating fatty liver disease and/or steatohepatitis
2. 12410192 - Compound for inhibiting and inducing degradation of EGFR kinase
3. 12398118 - Rho-associated protein kinase inhibitor, pharmaceutical composition comprising same, and use thereof
4. 12180243 - Receptor inhibitor, pharmaceutical composition comprising same, and use thereof
5. 11939578 - Double-stranded RNA molecule targeting CKIP-1 and use thereof
6. 11919918 - P2X3 andor P2X2/3 receptor antagonist, pharmaceutical composition comprising same, and use thereof
7. 11905274 - Receptor inhibitors, pharmaceutical compositions comprising the same and use thereof
8. 11453690 - Receptor inhibitor, pharmaceutical composition comprising same, and use thereof
9. 11414444 - P2X3 and/or P2X2/3 receptor antagonist, pharmaceutical composition comprising same, and use thereof
10. 11390609 - Rho-associated protein kinase inhibitor, pharmaceutical composition comprising same, and preparation method and use thereof
11. 11155819 - Double-stranded RNA molecule targeting CKIP-1 and use thereof
12. 10329282 - Rho-associated protein kinase inhibitor, pharmaceutical composition comprising the same, as well as preparation method and use thereof
13. 10323023 - Rho-associated protein kinase inhibitor, pharmaceutical composition comprising the same, as well as preparation method and use thereof